1) Scott JM, Khakoo A, Mackey JR, Haykowsky MJ, Douglas PS, Jones LW.
Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast
cancer: current evidence and underlying mechanisms. Circulation.
2011 Aug 2;124(5):642-50.
2) McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS.
Effects of exercise on breast cancer patients and survivors: a systematic review
and meta-analysis. CMAJ. 2006 Jul 4;175(1):34-41.
3) Beaudry RI, Liang Y, Boyton ST, Tucker WJ, Brothers RM, Daniel KM, Rao R, Haykowsky
MJ. Meta-analysis of Exercise Training on Vascular Endothelial Function in Cancer
Survivors. Integr Cancer Ther. 2018 Jun;17(2):192-199.
4) Doroshow JH, Tallent C, Schechter JE. Ultrastructural features of Adriamycin-
induced skeletal and cardiac muscle toxicity. Am J Pathol.
1985 Feb;118(2):288-97.
5) Klassen O, Schmidt ME, Ulrich CM, Schneeweiss A, Potthoff K, Steindorf K,
Wiskemann J. Muscle strength in breast cancer patients receiving different treatment
regimes. J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):305-316.
6) Gilchrist SC, Barac A, Ades PA, Alfano CM, Franklin BA, Jones LW, La Gerche A,
Ligibel JA, Lopez G, Madan K, Oeffinger KC, Salamone J, Scott JM, Squires RW,
Thomas RJ, Treat-Jacobson DJ, Wright JS; American Heart Association Exercise,
Cardiac Rehabilitation, and Secondary Prevention Committee of the Council on Clinical
Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Peripheral
Vascular Disease. Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes
in Cancer Patients and Survivors: A Scientific Statement From the American
Heart Association. Circulation. 2019 May 21;139(21):e997-e1012.
7) Sase K, Kida K, Furukawa Y. Cardio-Oncology rehabilitation- challenges and opportunities to improve cardiovascular outcomes in cancer patients and survivors.
J Cardiol. 2020 Dec;76(6):559-567.